A 3-Part Adaptive Design Study to Assess Safety, Tolerability and Efficacy of Treatment in Patients with Non-alcoholic Steatohepatitis (NASH)

August 15, 2018
https://clinicaltrials.gov/ct2/show/NCT02855164
Gastroenterology Hepatology
Principal Investigator: Kimberly A Brown, MD
nonalcoholic steatohepatitis, NASH, Nonalcoholic Steatohepatitis, nash, Non-alcoholic Steatohepatitis,
Open